FFA
BLUE

Fairfield Financial Advisors’s bluebird bio BLUE Stock Holding History

Fairfield Financial Advisors’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3
Closed -$25 – 86
2024
Q4 		$25 Hold
3
– – ﹤0.01% 263
2024
Q3 		$31 Hold
3
– – ﹤0.01% 290
2024
Q2 		$59 Buy
+3
New +$60 ﹤0.01% 290
2023
Q4 		$83 Hold
3
– – ﹤0.01% 311
2023
Q3 		$182 Hold
3
– – ﹤0.01% 296
2023
Q2 		$197 Hold
3
– – ﹤0.01% 308
2023
Q1 		$188 Hold
3
– – ﹤0.01% 315
2022
Q4 		$415 Hold
3
– – ﹤0.01% 301
2022
Q3 		$380 Hold
3
– – ﹤0.01% 312
2022
Q2 		$248 Hold
3
– – ﹤0.01% 300
2022
Q1 		$291 Buy
+3
New +$396 ﹤0.01% 303

Other funds holding BLUE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CIEC
Crédit Industriel et Commercial Paris France, France $1.55B AUM 42.08% 1-Year Est. Return
GLF
Groupe la Francaise Paris, France $7.29B AUM 37.28% 1-Year Est. Return
EPM
Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return

Fairfield Financial Advisors's BLUE Position: Q1 2025 in Review

Fairfield Financial Advisors sold out of bluebird bio (BLUE) in Q1 2025, closing a stake of 3 shares — an estimated $25 sold.

Fairfield Financial Advisors first reported a position in BLUE in Q1 2022 and held it in 11 quarters. The position peaked at $415 in Q4 2022. 85 funds tracked by Wall St. Rank hold BLUE as of Q1 2025.

  • Fairfield Financial Advisors reported no remaining bluebird bio position as of Q1 2025 after selling out during the quarter.
  • Fairfield Financial Advisors sold 3 bluebird bio shares in Q1 2025, an estimated $25.
  • Fairfield Financial Advisors first reported a position in bluebird bio in Q1 2022 and held it in 11 quarters.
  • Fairfield Financial Advisors's bluebird bio position peaked at $415 in Q4 2022.
  • 85 funds tracked by Wall St. Rank held bluebird bio as of Q1 2025.

Based on Fairfield Financial Advisors's 13F filing for Q1 2025, filed 9 May 2025.